De Novo Multiple Myeloma
1 clinical trials · Condition
◉ Watch De Novo Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST) (NCT07045909) | PETHEMA Foundation | 2025-06-30 |
Track De Novo Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.